Patent · US Active

Compounds for inflammation and immune-related uses

US7709518B2 · kind B2 · utility

30Cited by

23References

19Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Shoujun Chen · Bedford, US
Jun Jiang · Shanghai, CN
Hao Li · Brookline, US
David James · Cambridge, US
Dinesh U. Chimmanamada · Arlington, US
Christopher Borella · Bedford, US
Lijun Sun · Harvard, US
Yu Xie · Natick, US
Mats Holmqvist · Handen, SE
Jerome Mahiou · Lexington, US
Zhi-Qiang Xia · Acton, US

Key dates

Filing date	Sep 21, 2005
Grant date	May 4, 2010
Priority date	—
Expiry date	Oct 19, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.